StockData
Shoulder Innovations, Inc. logo

Shoulder Innovations, Inc. (SI) stock

SINYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 7/3051% above fair value
$20.65+0.09 (+0.44%)

Close on Nov 18, 2026Market cap $429.91MP/E –Yield –

Shoulder Innovations operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Shoulder Innovations's operating income for the twelve months ending Jun 30, 2026 was -$35.15M. For fiscal 2025 it was -$26.30M.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$26.30M–
FY2024Dec 31, 2024-$14.65M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$10.04M–
Q1 FY2026Mar 31, 2026-$8.98M–
Q4 FY2025Dec 31, 2025-$8.50M–
Q3 FY2025Sep 30, 2025-$7.64M–
Q2 FY2025Jun 30, 2025-$5.86M–
Q1 FY2025Mar 31, 2025-$4.29M–
Q4 FY2024Dec 31, 2024-$3.54M–
Q3 FY2024Sep 30, 2024-$3.88M–
Q2 FY2024Jun 30, 2024-$3.98M–

More Shoulder Innovations figures

See a number that looks wrong?